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Introduction: Calcific aortic valve disease(CAVD) is the most common indication for valve surgery. This study hypothesizes that calcific aortic valve 
disease develops secondary to Wnt3a/Lrp5 activation via oxidative- mechanical stress.
Methods: eNOS-/- mice were tested with experimental diets including a control (n=20), cholesterol (n=20), cholesterol + Atorvastatin (n=20). 
After 23 weeks the mice were tested for the development of aortic stenosis by Echo, Histology, MicroCT and RTPCR for bone markers. In vitro studies 
measured Wnt3a secretion from aortic valve endothelial cells and confirmed oxidative stress via eNOS activity. Myofibroblast cells were tested to 
induce bone formation.
Results: Cholesterol treated eNOS mice develop severe stenosis with an increase in Wnt3a, Lrp5, Cbfa1, (3-fold increase(p<0.0001) in the 
bicuspid versus tricuspid aortic valves. Secretion of Wnt3a from aortic valve endothelium in the presence of abnormal oxidative stress was 
correlated with diminished eNOS enzymatic activity and tissue nitrite levels. Osteoblastogenesis in the myofibroblast cell occurred via Lrp5 receptor 
upregulation in the presence of osteogenic media.
Conclusion: Targeting the Wnt3a/Lrp5 pathway in valve calcification and activation of osteogenesis is via an oxidative-mechanical stress in CAVD. 
These findings provide a foundation for treating this disease process.
 
